{"id":2871,"date":"2026-08-25T11:58:35","date_gmt":"2026-08-25T10:58:35","guid":{"rendered":"https:\/\/officialcorepeptides.brandloom.net\/en\/?post_type=product&p=2871"},"modified":"2026-08-25T11:58:36","modified_gmt":"2026-08-25T10:58:36","slug":"buy-lipopeptide-200mg-in-switzerland","status":"publish","type":"product","link":"https:\/\/officialcorepeptides.ch\/en\/product\/buy-lipopeptide-200mg-in-switzerland\/","title":{"rendered":"Lipopeptide (200MG)"},"content":{"rendered":"

What Is KPV and Why Buy It for Research?<\/strong><\/h2>\n

Buy KPV 4mg in Switzerland for research into anti-inflammatory pathways, immunomodulation, and cytoprotective mechanisms. Specifically, KPV (also known as Lys-Pro-Val or Tripeptide-1) is a synthetic tripeptide fragment of alpha-melanocyte stimulating hormone (\u03b1-MSH) with the amino acid sequence Lys-Pro-Val (KPV).<\/p>\n

KPV represents the C-terminal tripeptide sequence of \u03b1-MSH, a neuropeptide produced by the pituitary gland, immune cells, and other tissues. Importantly, KPV retains the potent anti-inflammatory and immunomodulatory properties of the parent hormone without the pigmentary (melanogenic) effects associated with full-length \u03b1-MSH. The peptide has a molecular weight of 357.45 g\/mol and the molecular formula C\u2081\u2086H\u2083\u2081N\u2085O\u2084.<\/p>\n

In scientific research, KPV serves as a molecular tool for studying melanocortin receptor signaling, inflammatory cytokine regulation, and immune system modulation. Furthermore, Core Peptides supplies KPV as a lyophilized powder in a 4mg format exclusively for laboratory use. Therefore, researchers seeking to source this compound for their work will find it readily available when they buy KPV 4mg in Switzerland.<\/p>\n

KPV Research Overview: Buy KPV 4mg in Switzerland for Anti-Inflammatory Studies<\/strong><\/h2>\n

Centrally, research into KPV has focused on its function as a potent anti-inflammatory and immunomodulatory peptide derived from the C-terminal region of \u03b1-MSH. \u03b1-MSH is a neuropeptide with well-documented anti-inflammatory, anti-pyretic, and antimicrobial activities. Notably, KPV is the smallest fragment of \u03b1-MSH that retains anti-inflammatory activity, making it a valuable tool for studying the melanocortin system’s role in inflammation.<\/p>\n

KPV exerts its effects through binding to melanocortin receptors, primarily MC1R and MC3R, which immune cells including macrophages, monocytes, and neutrophils express. This receptor binding triggers intracellular signaling cascades that modulate inflammatory responses. Furthermore, studies have shown that KPV inhibits the production of pro-inflammatory cytokines such as TNF-alpha, IL-1\u03b2, and IL-6 while promoting the release of anti-inflammatory cytokines like IL-10.<\/p>\n

Research has demonstrated that KPV effectively reduces inflammation in various preclinical models, including colitis, dermatitis, and sepsis. The peptide also exhibits cytoprotective effects by reducing oxidative stress and promoting tissue repair. Accordingly, researchers who buy KPV 4mg in Switzerland from Core Peptides can support their investigations into anti-inflammatory mechanisms, immune modulation, and cytoprotective pathways.<\/p>\n

How Does KPV Work in Research?<\/strong><\/h2>\n

Mechanistically, KPV’s proposed action involves functioning as a melanocortin receptor agonist that modulates immune responses and reduces inflammation through multiple signaling pathways. The peptide operates through several interconnected mechanisms.<\/p>\n

Melanocortin Receptor Binding<\/strong><\/h3>\n

KPV binds to melanocortin receptors, primarily MC1R and MC3R, which various immune cells express. This binding initiates intracellular signaling cascades that modulate immune responses. Researchers associate MC1R activation, in particular, with anti-inflammatory effects in multiple cell types.<\/p>\n

Cytokine Modulation<\/strong><\/h3>\n

KPV significantly modulates the production of inflammatory cytokines. Studies have shown that KPV inhibits pro-inflammatory cytokines including TNF-alpha, IL-1\u03b2, and IL-6 while promoting anti-inflammatory cytokine IL-10. Consequently, this cytokine regulation helps restore immune balance in inflammatory conditions.<\/p>\n

Inhibition of NF-\u03baB Signaling<\/strong><\/h3>\n

KPV suppresses the activation of nuclear factor kappa-B (NF-\u03baB), a key transcription factor involved in the expression of pro-inflammatory genes. By inhibiting NF-\u03baB signaling, KPV reduces the production of inflammatory mediators and promotes inflammation resolution.<\/p>\n

Macrophage Modulation<\/strong><\/h3>\n

KPV modulates macrophage activity, promoting a shift from pro-inflammatory (M1) to anti-inflammatory (M2) phenotypes. This macrophage polarization contributes to the resolution of inflammation and tissue repair.<\/p>\n

Why Is KPV Studied in Switzerland?<\/strong><\/h2>\n

Primarily, researchers study KPV because it represents a well-characterized anti-inflammatory tripeptide that enables investigation of melanocortin receptor signaling, cytokine modulation, and immune regulation. In fact, this compound offers a focused tool for studying the molecular mechanisms underlying inflammation, immune responses, and tissue protection.<\/p>\n

Research has demonstrated KPV’s relevance across multiple domains. In a study on experimental colitis, KPV significantly reduced colon inflammation in rodents. The peptide also demonstrated efficacy in dermatitis models and in reducing oxidative stress markers. Furthermore, researchers have studied KPV for its potential to modulate the immune response in sepsis models and to protect against ischemia-reperfusion injury.<\/p>\n

KPV’s small size and stability make it an attractive research tool compared to larger peptides, and it offers a simple model for the anti-inflammatory activity of \u03b1-MSH. Ultimately, researchers who buy KPV 4mg in Switzerland gain access to a comprehensive research tool for investigating anti-inflammatory mechanisms, immunomodulation, and cytoprotective pathways.<\/p>\n

KPV Research Areas in Laboratory Studies<\/strong><\/h2>\n\n\n\n\n\n\n\n\n\n\n\n
Research Area<\/th>\nFocus<\/th>\nEvidence Level<\/th>\n<\/tr>\n<\/thead>\n
Anti-Inflammatory Research<\/td>\nCytokine modulation, NF-\u03baB inhibition, inflammation resolution<\/td>\nMechanistic \/ In Vitro \/ In Vivo<\/td>\n<\/tr>\n
Immunomodulation<\/td>\nMacrophage polarization, immune cell regulation, MC1R\/MC3R signaling<\/td>\nMechanistic \/ In Vitro<\/td>\n<\/tr>\n
Intestinal Inflammation<\/td>\nColitis models, inflammatory bowel disease, mucosal protection<\/td>\nAnimal \/ Preclinical<\/td>\n<\/tr>\n
Skin Inflammation<\/td>\nDermatitis models, wound healing, tissue protection<\/td>\nAnimal \/ Preclinical<\/td>\n<\/tr>\n
Sepsis Research<\/td>\nImmune response, cytokine storm, organ protection<\/td>\nAnimal \/ Preclinical<\/td>\n<\/tr>\n
Oxidative Stress<\/td>\nAntioxidant defense, ROS reduction, cytoprotection<\/td>\nMechanistic \/ In Vitro<\/td>\n<\/tr>\n
Ischemia-Reperfusion Injury<\/td>\nTissue protection, organ preservation, inflammatory response<\/td>\nPreclinical<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

KPV Compared With Related Research Compounds<\/strong><\/h2>\n\n\n\n\n\n\n\n\n
Compound<\/th>\nResearch Focus<\/th>\nMechanism \/ Target<\/th>\nKey Difference<\/th>\n<\/tr>\n<\/thead>\n
KPV<\/td>\nAnti-inflammatory, immunomodulation, cytoprotection<\/td>\nMC1R\/MC3R agonist, cytokine modulation<\/td>\nTripeptide; shortest \u03b1-MSH fragment retaining anti-inflammatory activity<\/td>\n<\/tr>\n
\u03b1-MSH<\/td>\nAnti-inflammatory, pigmentation, neuroprotection<\/td>\nMC1R-MC5R agonist<\/td>\nFull-length 13-amino acid peptide; includes pigmentary effects<\/td>\n<\/tr>\n
BPC-157<\/td>\nTissue healing, gastrointestinal protection<\/td>\nGrowth factor modulation, angiogenesis<\/td>\nDifferent mechanism; no melanocortin receptor involvement<\/td>\n<\/tr>\n
TB-500<\/td>\nTissue repair, wound healing<\/td>\nActin binding, cell migration<\/td>\nDifferent mechanism; no melanocortin receptor involvement<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Comparatively, KPV differs from full-length \u03b1-MSH in its size and research applications. On the one hand, \u03b1-MSH is a 13-amino acid peptide that exerts both anti-inflammatory and pigmentary effects through multiple melanocortin receptors. On the other hand, KPV is a tripeptide fragment that retains the anti-inflammatory properties without the pigmentary effects, making it a more focused tool for inflammation research. In contrast, BPC-157 and TB-500 operate through entirely different mechanisms unrelated to the melanocortin system.<\/p>\n

Research Applications for KPV in Switzerland<\/strong><\/h2>\n

Scientists have investigated KPV across several research domains:<\/p>\n